title: [Clinical study of Wenxikeli treatment of viral myocarditis].
abstract: OBJECTIVE
  To observe Wenxinkeli viral myocarditis clinical efficacy and safety.
  
  
  METHODS
  45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks.
  
  
  RESULTS
  The treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05).
  
  
  CONCLUSIONS
  Wenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.
authors.affiliation: The People's Liberation Army, General Hospital, The First Affiliated Hospital of Heart Medicine, Beijing 100037, China.
authors.forename: Hong-yan
authors.initials: HY
authors.lastname: Sun
mesh_terms: D000293:Adolescent; D000328:Adult; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy* / Q000821:virology*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal